CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 306 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03658889
NCT03658889N/ACompleted

Cross-sectional, Multicentre, Non-interventional Study to Assess Giant Cell Arteritis Medical Practices in France

Chugai Pharma France·observational·Posted Sep 6, 2018·Updated Jul 22, 2022

In Brief

An observational study for Giant Cell Arteritis. Completed, enrolled 306 participants across 1 site.

Detailed Summary

The purpose of this study is to describe medical practices in patients with GCA in terms of patient journey, diagnostic methods and specific GCA treatments since diagnosis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
CollaboratorsITEC Services

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 6, 2018
Enrollment StartAug 2, 2018
Primary CompletionNov 9, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.8 years ago